Re: Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25)
Sheng Yu, MD, Xiushen Wang, MD, Hong Ge, MD; Re: Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintena
Authors
- Xiushen Wang (ORCID: https://orcid.org/0000-0002-3639-6719)
- Hong Ge (ORCID: https://orcid.org/0000-0002-2958-3866)
- Yu Sg
Institutions
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2026-06-30
- DOI
- https://doi.org/10.1093/jnci/djag212
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00